The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations.

Abou Dalle I, Galimard JE, Poire X, Sanz J, Huynh A, Kröger N, Wagner-Drouet EM, Burns D, Eder M, Lioure B, Wu D, Mayer J, Carlson K, Stelljes M, Collin M, Aljurf M, Nagler A, Esteve J, Ciceri F, Bazarbachi A, Mohty M.

Open source

DOI
10.1038/s41409-025-02765-1
Published
2025-12-23
Container
Bone Marrow Transplant
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41409-025-02765-1,
  title = {The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations.},
  author = {Abou Dalle I and  Galimard JE and  Poire X and  Sanz J and  Huynh A and  Kröger N and  Wagner-Drouet EM and  Burns D and  Eder M and  Lioure B and  Wu D and  Mayer J and  Carlson K and  Stelljes M and  Collin M and  Aljurf M and  Nagler A and  Esteve J and  Ciceri F and  Bazarbachi A and  Mohty M.},
  year = {2026},
  journal = {Bone Marrow Transplant},
  doi = {10.1038/s41409-025-02765-1},
  url = {https://doi.org/10.1038/s41409-025-02765-1}
}

RIS

TY  - JOUR
TI  - The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations.
AU  - Abou Dalle I
AU  -  Galimard JE
AU  -  Poire X
AU  -  Sanz J
AU  -  Huynh A
AU  -  Kröger N
AU  -  Wagner-Drouet EM
AU  -  Burns D
AU  -  Eder M
AU  -  Lioure B
AU  -  Wu D
AU  -  Mayer J
AU  -  Carlson K
AU  -  Stelljes M
AU  -  Collin M
AU  -  Aljurf M
AU  -  Nagler A
AU  -  Esteve J
AU  -  Ciceri F
AU  -  Bazarbachi A
AU  -  Mohty M.
PY  - 2026
JO  - Bone Marrow Transplant
DO  - 10.1038/s41409-025-02765-1
UR  - https://doi.org/10.1038/s41409-025-02765-1
ER  - 

APA

I, A. D., JE, G., X, P., J, S., A, H., N, K., EM, W., D, B., M, E., B, L., D, W., J, M., K, C., M, S., M, C., M, A., A, N., J, E., F, C., A, B., & M., M. (2026). The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations.. Bone Marrow Transplant. https://doi.org/10.1038/s41409-025-02765-1

Source records